This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.
Early-Stage Alzheimer Primer: Pathophysiology, Diagnosis, and Assessment
Alzheimer disease (AD) is the most common cause of dementia; in the United States alone, approximately 5.8 million people are living with the disease. This slide presentation offers education about AD pathogenesis, trajectory, and diagnostic criteria from the Diagnostic and Statistical Manual of Disorders, Fifth Edition, and from the National Institute on Aging–Alzheimer’s Association. To diagnose mild cognitive impairment and early-stage AD, clinicians should employ a stepwise process that includes the following: cognitive screening, laboratory assessments, structural imaging of the brain, full neuropsychologic assessment (if warranted), and biomarker confirmation.
To cite: Apostolova L. Early-stage Alzheimer primer: pathophysiology, diagnosis, and assessment. J Clin Psychiatry. 2021;82(3):BG20044WC1C.
To share: https://doi.org/10.4088/JCP.BG20044WC1C
© Copyright 2021 Physicians Postgraduate Press, Inc.
aIndiana University School of Medicine, Indianapolis.